高齢者2型糖尿病向け個別化在宅日常ケアガイド作成

家

AIプロンプト一覧

医療健康

地域コミュニティ糖尿病在宅ケアガイド作成

${:__('collect %s',地域コミュニティ糖尿病在宅ケアガイド作成)}$

医療健康

地域に住む高齢の2型糖尿病患者の日常習慣、食の好み、併存疾患をもとに、実践可能な個別化在宅ケアガイドを生成します

プロンプト内容

コピー

Based on the daily routine, diet preference, comorbidities and current blood glucose control level provided by elderly community-dwelling type 2 diabetes patients, create a personalized home daily care guide that fits ordinary family operation conditions and is easy for middle-aged and elderly people to remember and follow. The guide covers daily diet matching, activity intensity suggestions, blood glucose monitoring frequency and abnormal response methods, with plain language that avoids complex jargon and adapts to home scenario implementation.

コピー

地域に住む高齢の2型糖尿病患者から提供された日常の習慣、食の好み、併存している他の基礎疾患、現在の血糖コントロール状況をもとに、一般家庭で実施でき、高齢者が覚えて実践しやすい個別化された在宅日常ケアガイドを作成します。内容には毎日の食事の組み合わせ、運動強度の推奨、血糖値測定の頻度と異常時の対処方法を含み、わかりやすい言葉で専門用語を避け、在宅環境で実践しやすい内容にまとめてください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following simulated prescription: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and Ibuprofen 400mg tid (for osteoarthritis pain). Analyze if there are drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of NSAID use in patients with renal impairment, and provide specific adjustment suggestions or alternative plans to ensure medication safety and compliance with clinical guidelines.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness, while flagging any risks according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's hepatic and renal function status. Identify any risk points based on the latest clinical guidelines, and finally provide adjustment suggestions or confirm safety, ensuring the output is concise and clinically actionable.